Global Hepatitis Report 2017. Geneva: World Health Organisation; 2017. License: CC BY-NC-SA 3.0 IGO.
Gentile I, Borgia G. Vertical transmission of hepatitis B virus: challenges and solutions. Int J Womens Health. 2014;6:605–11.
PubMed PubMed Central Google Scholar
Joshi SS, Coffin CS. Hepatitis B and pregnancy: virologic and immunologic characteristics. Hepatol Commun. 2020;4(2):157–71.
Article PubMed PubMed Central Google Scholar
Raimondo G, Locarnini S, Pollicino T, Levrero M, Zoulim F, Lok AS. Taormina Workshop on Occult HBVIFM. Update of the statements on biology and clinical impact of occult hepatitis B virus infection. J Hepatol. 2019;71(2):397–408.
Mulrooney-Cousins PM, Chauhan R, Churchill ND, Michalak TI. Primary seronegative but molecularly evident hepadnaviral infection engages liver and induces hepatocarcinoma in the woodchuck model of hepatitis B. PLoS Pathog. 2014;10(8): e1004332.
Article PubMed PubMed Central Google Scholar
Shahmoradi S, Yahyapour Y, Mahmoodi M, Alavian SM, Fazeli Z, Jazayeri SM. High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG. J Hepatol. 2012;57(3):515–21.
Yokoyama K, Kumagai H, Takahashi M, Nagashima S, Okamoto H, Yamagata T. Occult hepatitis B virus infection in immunized children born to carrier mothers. Pediatr Int. 2017;59(9):1010–6.
Article CAS PubMed Google Scholar
Hsu HY, Chen HL, Wu JF, Ni YH, Chang KC, Chiang CL, et al. Occult Hepatitis B Virus infection in immunized infants born to untreated and tenofovir-treated highly viremic mothers. Clin Gastroenterol Hepatol. 2021;19(7):1494–6.
Article CAS PubMed Google Scholar
Eilard A, Andersson M, Ringlander J, Wejstal R, Norkrans G, Lindh M. Vertically acquired occult hepatitis B virus infection may become overt after several years. J Infect. 2019;78(3):226–31.
Malmstrom S, Berglin-Enquist I, Lindh M. Novel method for genotyping hepatitis B virus on the basis of TaqMan real-time PCR. J Clin Microbiol. 2010;48(4):1105–11.
Article PubMed PubMed Central Google Scholar
Zhang H, Pan CQ, Pang Q, Tian R, Yan M, Liu X. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice. Hepatology. 2014;60(2):468–76.
Article CAS PubMed Google Scholar
Chen HL, Lee CN, Chang CH, Ni YH, Shyu MK, Chen SM, et al. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus. Hepatology. 2015;62(2):375–86.
Article CAS PubMed Google Scholar
Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y, et al. Tenofovir to prevent Hepatitis B transmission in mothers with high viral load. N Engl J Med. 2016;374(24):2324–34.
Article CAS PubMed Google Scholar
Jourdain G, Ngo-Giang-Huong N, Harrison L, Decker L, Khamduang W, Tierney C, et al. Tenofovir versus placebo to prevent perinatal transmission of Hepatitis B. N Engl J Med. 2018;378(10):911–23.
Article CAS PubMed PubMed Central Google Scholar
Funk AL, Lu Y, Yoshida K, Zhao T, Boucheron P, van Holten J, et al. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis. Lancet Infect Dis. 2021;21(1):70–84.
Article CAS PubMed Google Scholar
Boucheron P, Lu Y, Yoshida K, Zhao T, Funk AL, Lunel-Fabiani F, et al. Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis. Lancet Infect Dis. 2021;21(1):85–96.
Article CAS PubMed Google Scholar
Elefsiniotis IS, Tsoumakas K, Papadakis M, Vlachos G, Saroglou G, Antsaklis A. Importance of maternal and cord blood viremia in pregnant women with chronic hepatitis B virus infection. Eur J Intern Med. 2011;22(2):182–6.
Liu Y, Wen J, Chen J, Xu C, Hu Y, Zhou YH. Rare detection of occult hepatitis B virus infection in children of mothers with positive hepatitis B surface antigen. PLoS ONE. 2014;9(11): e112803.
Article PubMed PubMed Central Google Scholar
Weis N, Cowan S, Hallager S, Drose S, Kristensen LH, Gronbaek K, et al. Vertical transmission of hepatitis B virus during pregnancy and delivery in Denmark. Scand J Gastroenterol. 2017;52(2):178–84.
Article CAS PubMed Google Scholar
Pande C, Sarin SK, Patra S, Kumar A, Mishra S, Srivastava S, et al. Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial. J Viral Hepat. 2013;20(11):801–10.
Article CAS PubMed Google Scholar
Wu J, He J, Xu H. Global prevalence of occult HBV infection in children and adolescents: a systematic review and meta-analysis. Ann Hepatol. 2024;29(1): 101158.
Article CAS PubMed Google Scholar
Chen ZX, Gu GF, Bian ZL, Cai WH, Shen Y, Hao YL, et al. Clinical course and perinatal transmission of chronic hepatitis B during pregnancy: a real-world prospective cohort study. J Infect. 2017;75(2):146–54.
Rodriguez Lay LLA, Bello Corredor M, Montalvo Villalba MC, Chibas Ojeda AG, Sariego Frometa S, Diaz Gonzalez M, et al. Hepatitis B virus infection assessed 3 to 18 years after vaccination in Cuban children and adolescents born to HBsAg-positive mothers. Arch Virol. 2017;162(8):2393–6.
Article CAS PubMed Google Scholar
Yao QQ, Dong XL, Wang XC, Ge SX, Hu AQ, Liu HY, et al. Hepatitis B virus surface antigen (HBsAg)-positive and HBsAg-negative hepatitis B virus infection among mother-teenager pairs 13 years after neonatal hepatitis B virus vaccination. Clin Vaccine Immunol. 2013;20(2):269–75.
Article CAS PubMed PubMed Central Google Scholar
Zhou S, Li T, Allain JP, Zhou B, Zhang Y, Zhong M, et al. Low occurrence of HBsAg but high frequency of transient occult HBV infection in vaccinated and HBIG-administered infants born to HBsAg positive mothers. J Med Virol. 2017;89(12):2130–7.
Article CAS PubMed Google Scholar
Su H, Zhang Y, Xu D, Wang B, Zhang L, Li D, et al. Occult hepatitis B virus infection in anti-HBs-positive infants born to HBsAg-positive mothers in China. PLoS ONE. 2013;8(8): e70768.
Article CAS PubMed PubMed Central Google Scholar
Foaud H, Maklad S, Mahmoud F, El-Karaksy H. Occult hepatitis B virus infection in children born to HBsAg-positive mothers after neonatal passive-active immunoprophylaxis. Infection. 2015;43(3):307–14.
Article CAS PubMed Google Scholar
Hu AQ, Cai QY, Zhang M, Liu HY, Wang TL, Han WH, et al. Overt and occult hepatitis B infection after neonatal vaccination: mother-to-infant transmission and HBV vaccine effectiveness. Int J Infect Dis. 2021;104:601–9.
Article CAS PubMed Google Scholar
Chakvetadze C, Roussin C, Roux J, Mallet V, Petinelli ME, Pol S. Efficacy of hepatitis B sero-vaccination in newborns of African HBsAg positive mothers. Vaccine. 2011;29(16):2846–9.
Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008;49(4):652–7.
Chen HL, Lin LH, Hu FC, Lee JT, Lin WT, Yang YJ, et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology. 2012;142(4):773-81.e2.
Segeral O, Dim B, Durier C, Nhoueng S, Chhim K, Sovann S, et al. Immunoglobulin-free strategy to prevent HBV mother-to-child transmission in Cambodia (TA-PROHM): a single-arm, multicentre, phase 4 trial. Lancet Infect Dis. 2022;22(8):1181–90.
Article CAS PubMed Google Scholar
Zhang W, Xu C, Rui Y, Chen J, Chen T, Dai Y, et al. Efficacy of the hepatitis B vaccine alone in the prevention of hepatitis B perinatal transmission in infants born to hepatitis B e antigen-negative carrier mothers. J Virus Erad. 2022;8(2): 100076.
Comments (0)